While advances in diagnosis and treatment have been extraordinary in the last twenty years in terms of our understanding of the brain and length of life for sufferers from brain disorders such as stroke, severe trauma or degenerative diseases, the quality of life and the ability to continue functioning independently in the community have received much less attention and demonstrated little progress until recently. NURO has markedly changed that picture with the release of NUOS.

By developing neuroscience-based assistive technologies that were unimaginable even five years ago, NURO has the potential to make life-altering changes in the capacity to communicate for these patients.

Dr. David J. Kupfer, M.D.

NURO’s technology is a breakthrough device to give back to patients their dignity and independence.

Regaining the ability to communicate with the external world when your speaking capabilities are severely impaired by neurovascular, neuromuscular or neurodegenerative diseases will impact the patients’ and the caregivers’ quality of life in an unprecedented manner.

Dr. Fouzia Laghrissi-Thode, M.D., Ph.D.

As the largest health system in New York City, the Department of Rehabilitation Medicine at the Mount Sinai Health System provides care for tens of thousands of individuals living with spinal cord injury, traumatic brain injury and stroke.

A major priority for the health system is to not only provide the highest possible standard of care to these people, but to also lead the world in providing technologically advanced options for care.

As a researcher with a strong background in both EEG technology and Brain Computer Interface applications, I see very real potential for this technology to significantly improve quality of life for many of our patients.

I recently reviewed NURO’s technology and was impressed at both the potential of the early-stage technology to help people who are in need of augmentative communication technologies, as well as the company’s commitment to significantly disrupting the price-point of existing technology in this class. Affordability of technology of this nature is a major barrier to many of the families that need it, and I am very excited that NURO Corp is attempting to address this issue.

We are looking forward to the ability to offer this ground-breaking technology to our patients.

David Putrino, P.T., Ph.D.

I interface with over 100 emerging health tech companies a year and, in the past 5 years, I have not seen anything that compares to the ability and the value that the NUOS system offers patients to drive a new, non-invasive communication paradigm.

Spread the word !

Martin ('Marty') Gurbin

We are already convinced and sold regarding the access potential of your technology.  We don’t know of anything else like it.

I see so many applications for your technology and could see any clinician who has difficulties finding a way to communicate with patients who are physically impaired (even profoundly) use NUOS for assessment, information gathering and all the way up to independent communication.

Our team would very much like to share the ways in which we think we can support the use of your technology for patients that would be eligible to see us.

In fact, I think it has the potential to change and expand the criteria for eligibility.

Anonymous